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Aim To determine whether antemortem blood levels of 
glycated hemoglobin (HbA1c) and glucose predict com-
pleted suicide and, by extension, whether markers of glu-
cose metabolism might be associated with a prosuicidal 
trait or state.
Method From consecutively performed autopsies, sam-
ples of blood and vitreous humor from 17 suicide victims 
and 27 non-suicide controls were compared with regard to 
levels of glucose, lactate, and HbA1c.
Results Mean HbA1c was higher, and mean estimated 
blood glucose lower, among suicide victims, although 
tests revealed no significant differences (P = 0.171 and P 
= 0.395, respectively). HbA1c levels exceeding 48.0 mmol/
mol, which were indicative of persistent hyperglycemia, 
were twice as common in suicide victims (59% vs 30%; 
P = 0.068).
Conclusion The finding of this pilot study suggest that de-
ranged glucose metabolism may reflect biological events 
antecedent to, or concomitant with, completed suicide, 
with the following clinical implications: recurring hyper-
glycemia due to defective glucose transport, which may 
give rise to depression and suicidal ideation, and elevated 
HbA1c levels, which may represent an assayable correlate 
to neurobiological conditions predisposing to suicide.
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Mood disorders are overrepresented in cases of complet-
ed suicide (1-4). Observational studies have shown that 
a diagnosis of diabetes mellitus – a condition character-
ized by persistent hyperglycemia – is associated with an 
increased risk of depression and anxiety in both adoles-
cents and adults (5-10). In a recent cohort study of over 
1.2 million Korean men and women, a single elevated 
fasting blood-glucose measurement was found to confer 
a two- to 3-fold increased risk of completed suicide dur-
ing a 14-year follow-up (11), while a recent registry-based 
matched cohort study of the entire Swedish population 
demonstrated a 3.4-fold risk increase for suicide among 
subjects afflicted with diabetes (12). However, the mecha-
nism by which deranged glucose metabolism could lead 
to suicide remains elusive.
Glucose is a ubiquitous source of energy, and under nor-
mal metabolic conditions—in the absence of fasting or 
other states of starvation—it is the human brain’s primary 
source of cellular fuel. Psychological processes such as self-
control, decision making and regulation of emotions de-
pend heavily on intracellular availability of glucose in the 
brain (13,14).
It has been suggested that dysregulation of emotions—
resulting in aggressive impulses, pessimism and impulsiv-
ity—occurs more commonly among suicide attempters 
(15,16). Further, in males, aggressiveness and impulsivity 
have been shown to be associated to lower blood glucose 
levels (17). Although previous studies have identified sev-
eral biochemical markers in completed suicide (18-20), to 
our knowledge no study has attempted to characterize the 
state of glucose metabolism in the weeks, hours and min-
utes prior to the suicidal act.
Hyperglycemia results from a reduced ability of cells to 
take up circulating glucose, on account of either insulin 
deficiency or insulin resistance. Elevated blood glucose 
levels can thus be interpreted as a sign of intracellular glu-
cose deficiency. In the clinic, states of acute and chronic 
hyperglycemia are diagnosed by way of measurements in 
blood of glucose and glycosylated hemoglobin (HbA1c), re-
spectively. While blood glucose reflects the current glyce-
mic state, HbA1c—formed by non-enzymatic coupling of 
glucose and hemoglobin—reflects blood glucose levels 
over the past one to three months.
In the present pilot study, we compared subjects who had 
undergone forensic autopsy, grouped according to cause 
of death, to determine the extent to which glucose me-
tabolism was deranged in the period preceding the sui-
cidal act. We compared the estimated blood glucose and 
HbA1c concentrations in cases of completed suicide and 
controls. In addition, we compared frequencies of subjects 
in each group whose HbA1c concentrations exceeded the 




Beginning in November 2012, in the course of 51 con-
secutive medico-legal autopsies performed at the De-
partment of Forensic Medicine of the Hjelt Institute of the 
University of Helsinki, samples were collected post mor-
tem according to standard procedures. All autopsies were 
conducted by the same forensic team, headed by a single 
pathologist.
At the time of autopsy, causes of death were determined 
and coded according to the International Statistical Clas-
sification of Disease, 10th revision (ICD-10). Subjects were 
divided into two groups according to ICD-10 codes: those 
who had died of suicide (ICD-10 codes X64-X84) and 
those who had died on account of other causes, including 
events of undetermined intent (ICD-10 codes Y10- Y34), 
who made up the control group.
Seven of the 51 subjects in original sample were excluded 
due to either protracted processes of postmortem decay, 
which made sampling impossible, or hemolysis of collect-
ed blood samples. Thus, a total of 44 individuals were in-
cluded in the statistical analysis. Clinical and demographic 
data, as well as results of standard toxicological screening, 
were available for all 44 subjects.
Samples
Samples of blood and vitreous humor were collected from 
the femoral vein and vitreous chamber according to stan-
dard forensic procedures. Levels of HbA1c in blood were 
determined by high-pressure liquid chromatography us-
ing Mono-S cation-exchange columns, followed by con-
version to the unit mmol/mol, as recommended by the In-
ternational Federation of Clinical Chemistry (21).
Concentrations of glucose and lactic acid were deter-
mined by standard enzymatic assays, as described by 
Sippel and Möttönen (22). In accordance with for-
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mula of Traub, the sum of postmortem concentrations in 
vitreous humor of glucose and lactate was used to esti-
mate antemortem glycemic state. Because levels of lactate 
in vitreous humor increase linearly with the duration of the 
postmortem interval (23), Traub-index levels were, for giv-
en individuals, not regarded as accurate estimates of ante-
mortem blood glucose levels.
Statistical analysis
Blood HbA1c and Traub-index levels were compared in sui-
cide victims and controls using Wilcoxon rank-sum test 
and Welch’s t test, respectively. In addition, frequencies of 
subjects in each group with blood HbA1c levels exceeding 
the threshold for persistent hyperglycemia, as defined by 
the World Health Organization (24,25), were compared us-
ing Fisher’s exact test. Uncorrected P < 0.05 were regarded 
as statistically significant. All statistical analyses were per-
formed using R (ver. 3.1.3) (26).
RESULTS
The mean age at death and gender distribution were com-
parable between groups (Table 1). In the suicide group, 
physical trauma contributing to death was more com-
mon and pre-existing somatic illness less common. Anti-
depressants were detected in blood at similar rates in both 
groups. There were differences between groups with re-
gard to the detection in postmortem blood of ethanol, as 
well as antidiabetic and antipsychotic medications — sub-
stances whose antemortem use may affect blood-glucose 
levels. With the exception of illicit drugs, all other analyzed 
substances, including alcohol, occurred more commonly 
in the non-suicide group.
Of the 44 subjects, 17 were adjudged to have commit-
ted suicide and 27 to have died of other causes. Among 
the suicide victims, specific causes of death were hanging 
(n = 7), gunshot wounds (n = 5), poisoning (n = 3), exposure 
TABLE 1. Demographic and toxicological data by cause of death in suicide vs non-suicide subjects
No. (%) of subjects
Demographic characteristics suicide (n = 17) non-suicide (n = 27)
Male 11 (65.0) 18 (67.0)
Age (years; mean±SD; median, range)* 55.0 ± 19.5 (63.5, 24-86) 59.3 ± 21.0 (58.3, 21-93)
Physical trauma involved 14 (82.0)  7 (26.0)
Known somatic illness  1 (6.0) 20 (74.0)
Toxicological characteristics (number positive)
Ethanol  4 (24.0) 11 (41.0)
Benzodiazepines  5 (29.0) 11 (41.0)
Opiates  2 (12.0)  9 (33.0)
Other narcotic substances†  3 (18.0)  2 (7.0)
Antidepressants  4 (24.0)  8 (30.0)
Antipsychotics  1 (6.0)  5 (19.0)
Antidiabetic medications  0 (0.0)  2 (7.0)
*SD – standard deviation.
†Cannabis, amphetamine.
TABLE 2. Glycemic biomarkers by cause of death in suicide vs non-suicide subjects
Bimarker concentration (mean±SD; median, range)*
Biomarker suicide (n = 17) non-suicide (n = 27) P
Vitreous glucose, mmol/L  0.9 ± 2.1 (0.0, 0.0-7.0)  1.5 ± 2.9 (0.0, 0.0-11.9)
Vitreous lactate, mmol/L 32.5 ± 5.1 (32.4, 23.3-39.1) 33.9 ± 8.4 (34.9, 16.5-45.8)
Vitreous Traub†, mmol/L 33.4 ± 4.9 (32.7; 23.3-41.1) 35.3 ± 9.8 (34.9, 17.2-56.7) 0.395‡
Blood HbA1c, mmol/L 51.1 ± 14.7 (48.4, 35.6-97.8) 46.6 ± 13.8 (43.2, 21.9-99.6) 0.171
§
Blood HbA1c (%)>48.0 mmol/mol (SEM) 59.0 (5.03) 30.0 (5.80) 0.068
II
*SD = standard deviation; SEM = standard error of the mean.
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to fire (n = 1), and contact with a moving vehicle (n = 1). 
Among the non- suicide controls, specific causes of death 
were cardiovascular disease (n = 6), accidental poisoning 
(n = 6), falling accidents (n = 5), alcohol-related organ dam-
age (n = 3), infectious disease (n = 2), homicide (n = 1), traf-
fic accident (n = 1), Alzheimer disease (n = 1), and unknown 
causes (n = 2).
Glucose
One subject in the non-suicide group displayed elevated 
ketone bodies in the absence of hyperglycemia and other 
findings indicative of alcohol-induced ketoacidosis. Mean 
values of Traub index, based on glucose and lactate mea-
surements in the vitreous humor, did not differ significant-
ly between the suicide and non-suicide group (35.3 ± 9.8 
mmol/L vs 33.4 ± 4.9 mmol/L, respectively, P = 0.395; Table 
2). Prior to analysis, the Shapiro-Wilk normality test had re-
vealed that the values were normally distributed, allowing 
the use of a parametric test.
HbA1c
HbA1c levels measured in postmortem blood were, on av-
erage, higher among suicide victims than among subjects 
who had died of other causes (51.1 ± 14.7 mmol/mol vs 
46.6 ± 13.8 mmol/mol, respectively; Table 2); however, the 
Shapiro-Wilk normality test revealed that the values were 
not normally distributed, necessitating the use of a non-
parametric test. When tested using the Wilcoxon rank-sum 
test, the groups did not differ significantly with regard to 
HbA1c levels (P = 0.171; Table 2). In addition, HbA1c values 
exceeding the WHO threshold for dysregulated glucose 
metabolism (48.0 mmol/mol, recommended for use in di-
agnosing diabetes mellitus ante mortem) were twice as 
common in the suicide group, compared to the non- sui-
cide group (59% vs 30%, P = 0.068; Table 2 and Figure 1). 
The specific causes of death in subjects with HbA1c values 
exceeding 48.0 mmol/mol were, among suicide victims 
hanging (n = 4), gunshot wounds (n = 3), poisoning (n = 1), 
exposure to fire (n = 1) and contact with a moving vehicle 
(n = 1); and, among non-suicide controls, cardiovascular 
disease (n = 4), falling accidents (n = 2), accidental poison-
ing (n = 1) and traffic accident (n = 1).
DISCUSSION
In the present study of glycemic biomarkers in consecu-
tive forensic autopsies, ranked HbA1c levels were found 
to be higher, albeit nonsignificantly, in subjects who had 
committed suicide than subjects who had died of other 
causes. Similarly, in two recent studies, HbA1c levels were 
associated with suicidal ideation in subjects with either 
previously diagnosed (27) or undiagnosed (28) diabetes. 
The authors of the former study speculate that elevated 
HbA1c levels may reflect poor self-care associated with de-
pression; whereas the authors of the latter study propose 
that defective glucose transport, resulting in recurring hy-
perglycemia, in itself may directly give rise to depression 
and suicidal ideation–may in other words, constitute a per-
sisting, prosuicidal “trait.”
In the present study, we have also investigated whether 
glucose metabolism might play a role in the prosuicid-
al “state” – the suicidal act’s concomitant neurobiological 
substrate. We found that estimated antemortem blood 
glucose levels were slightly lower in subjects who had 
committed suicide than in subjects who had died of other 
causes, including somatic illness – although again the dif-
ference was not statistically significant. In the present data 
FIGURE 1. HbA1c levels in postmortem blood by cause of death in suicide vs non-
suicide subjects. The red dashed line indicates threshold recommended by the World 
Health Organization for diagnosis of diabetes mellitus (48.0 mmol/mol). The blue 
dashed lines indicate the mean value of each group. Groups did not differ significantly 
with regard to HbA1c levels (P = 0.171); however, HbA1c values exceeding 48.0 mmol/
mol were twice as common in the suicide group (P = 0.068).
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set, however, the extent to which the duration of antemor-
tem agony differed between the two groups is unclear. An-
temortem agony is, of course, associated with the release 
of stress hormones resulting in, among other things, tran-
sient elevation of blood glucose. By the same token, the 
reliability of approximations of antemortem blood glucose 
concentration, using Traub’s formula, is inversely propor-
tionate to the postmortem interval (23), which, in Finland, 
as has been previously reported, is, on average, relatively 
long (29). Indeed, in a coming study in a large Swedish au-
topsy series, we hope to restrict our analysis of estimated 
blood glucose levels to cases of immediate death.
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